Inhibition and covalent modification of tyrosine hydroxylase by 3,4-dihydroxyphenylacetaldehyde, a toxic dopamine metabolite
- 1 August 2011
- journal article
- Published by Elsevier in NeuroToxicology
- Vol. 32 (4) , 471-477
Abstract
No abstract availableKeywords
Funding Information
- NIH
This publication has 49 references indexed in Scilit:
- Neuroprotective effects of salidroside against beta-amyloid-induced oxidative stress in SH-SY5Y human neuroblastoma cellsNeurochemistry International, 2010
- A Biochemical and Functional Protein Complex Involving Dopamine Synthesis and Transport into Synaptic VesiclesJournal of Biological Chemistry, 2010
- Protein Reactivity of 3,4-Dihydroxyphenylacetaldehyde, a Toxic Dopamine Metabolite, Is Dependent on Both the Aldehyde and the CatecholChemical Research in Toxicology, 2009
- Role of N-terminus of tyrosine hydroxylase in the biosynthesis of catecholaminesJournal of Neural Transmission, 2009
- Products of Oxidative Stress Inhibit Aldehyde Oxidation and Reduction Pathways in Dopamine Catabolism Yielding Elevated Levels of a Reactive IntermediateChemical Research in Toxicology, 2009
- Dopamine covalently modifies and functionally inactivates parkinNature Medicine, 2005
- Oxidative stress in Parkinson's diseaseAnnals of Neurology, 2003
- Overexpression of the Protein Phosphatase 2A Regulatory Subunit Bγ Promotes Neuronal Differentiation by Activating the MAP Kinase (MAPK) CascadeJournal of Biological Chemistry, 2002
- Empirical Statistical Model To Estimate the Accuracy of Peptide Identifications Made by MS/MS and Database SearchAnalytical Chemistry, 2002
- Kinetic Stabilization of the α-Synuclein Protofibril by a Dopamine-α-Synuclein AdductScience, 2001